Clinical Trial Update: Digital Monitoring of Self-reported Symptoms by Patients Treated With Cabozantinib Plus Nivolumab for Advanced Clear-cell Renal Carcinoma [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating digital monitoring of self-reported symptoms in patients with advanced renal cell carcinoma treated with the cabozantinib an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma
• Renal Cell Carcinoma Locally Advanced
• Renal Cell Carcinoma Metastatic

Drugs mentioned

• Cabometyx (cabozantinib)
• OPDIVO (nivolumab)

Snippet

Sponsor: Centre Francois Baclesse | Conditions: Renal Cell Carcinoma (Kidney Cancer), Metastatic Renal Cell Carcinoma | Phase 4 | Status: RECRUITING